FTC, Wholesalers Amend AndroGel Complaints

By Morgan Bettex

Law360, New York (May 29, 2009, 12:00 AM ET) -- The Federal Trade Commission and three drug wholesalers representing buyers of the testosterone supplement AndroGel have filed second amended complaints in their suits against several drugmakers claiming patent settlements over the drug thwarted competition and denied the buyers cheaper generics.

The FTC, Meijer Inc., Rochester Drug Cooperative Inc. and the Louisiana Wholesale Drug Co. Inc. each filed their amended complaints Wednesday in the U.S. District Court for the Northern District of Georgia in order to meet a deadline imposed by Judge Thomas W. Thrash Jr. when...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles